| Name |
Zegluxen 6 mg/ml otopina za injekciju u napunjenoj brizgalici |
| Marketing Authorisation Number |
HR-H-485086578 |
| Active Substance |
liraglutid |
| Composition |
1 ml otopine sadrži 6 mg liraglutida |
| Pharmaceutical Form |
Otopina za injekciju u napunjenoj brizgalici |
| Manufacturer |
Pharmadox Healthcare Limited, Paola, Malta |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
16.01.2025 |
| MA Period of Validity |
16.01.2030 |
| Classification Number |
UP/I-530-09/22-01/289 |
| Registration Number |
381-12-01/70-25-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A10BJ02 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
